Immunohistochemistry on tumor specimens and flow cytometry blood samples revealed decreased Tregs and MDSCs with increase in CD8+ T cells and CD68+ HLA-Dr+ CD163+ myeloid dendritic cells [10]. The gene discussed is CD8A; the disease is neoplasm.